Stockreport

Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 [Yahoo! Finance]

Cadrenal Therapeutics, Inc.  (CVKD) 
PDF biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced that it will participate in a webcast p [Read more]